Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael J. Rodriguez is active.

Publication


Featured researches published by Michael J. Rodriguez.


Biofutur | 1997

Glycopeptide antibiotic derivatives

Robin D. G. Cooper; Bret E. Huff; Thalia I. Nicas; John Thomas Indianapolis Quatroche; Michael J. Rodriguez; Nancy June Snyder; Michael A. Staszak; Richard Craig Thompson; Stephen Charles Wilkie; Mark J. Zweifel

The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.


Angewandte Chemie | 2015

Selective Monoarylation of Primary Amines Using the Pd-PEPPSI-IPentClPrecatalyst

Sepideh Sharif; Richard P. Rucker; Nalin Chandrasoma; David Mitchell; Michael J. Rodriguez; Robert D. J. Froese; Michael G. Organ

A single set of reaction conditions for the palladium-catalyzed amination of a wide variety of (hetero)aryl halides using primary alkyl amines has been developed. By combining the exceptionally high reactivity of the Pd-PEPPSI-IPent(Cl) catalyst (PEPPSI=pyridine enhanced precatalyst preparation, stabilization, and initiation) with the soluble and nonaggressive sodium salt of BHT (BHT=2,6-di-tert-butyl-hydroxytoluene), both six- and five-membered (hetero)aryl halides undergo efficient and selective amination.


Angewandte Chemie | 2015

The Selective Cross‐Coupling of Secondary Alkyl Zinc Reagents to Five‐Membered‐Ring Heterocycles Using Pd‐PEPPSI‐IHeptCl

Bruce Atwater; Nalin Chandrasoma; David Mitchell; Michael J. Rodriguez; Matthew Pompeo; Robert D. J. Froese; Michael G. Organ

The ability to cross-couple secondary alkyl centers is fraught with a number of problems, including difficult reductive elimination, which often leads to β-hydride elimination. Whereas catalysts have been reported that provide decent selectivity for the expected (non-rearranged) cross-coupled product with aryl or heteroaryl oxidative-addition partners, none have shown reliable selectivity with five-membered-ring heterocycles. In this report, a new, rationally designed catalyst, Pd-PEPPSI-IHept(Cl), is demonstrated to be effective in selective cross-coupling reactions with secondary alkyl reagents across an impressive variety of furans, thiophenes, and benzo-fused derivatives (e.g., indoles, benzofurans), in most instances producing clean products with minimal, if any, migratory insertion for the first time.


Chemistry: A European Journal | 2016

Pd-PEPPSI-IHeptCl: A General-Purpose, Highly Reactive Catalyst for the Selective Coupling of Secondary Alkyl Organozincs

Bruce Atwater; Nalin Chandrasoma; David Mitchell; Michael J. Rodriguez; Michael G. Organ

Dichloro[1,3-bis(2,6-di-4-heptylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) (Pd-PEPPSI-IHept(Cl) ), a new, very bulky yet flexible Pd-N-heterocyclic carbene (NHC) complex has been evaluated in the cross-coupling of secondary alkylzinc reactants with a wide variety of oxidative addition partners in high yields and excellent selectivity. The desired, direct reductive elimination branched products were obtained with no sign of migratory insertion across electron-rich and electron-poor aromatics and all forms of heteroaromatics (five and six membered). Impressively, there is no impact of substituents at the site of reductive elimination (i.e., ortho or even di-ortho), which has not yet been demonstrated by another catalyst system to date.


Bioorganic & Medicinal Chemistry Letters | 2001

Syntheses and antifungal activities of novel 3-amido bearing pseudomycin analogues.

Yan-Zhi Zhang; Xicheng Sun; Douglas J. Zeckner; Roberta K Sachs; William L. Current; Jaswant Singh Gidda; Michael J. Rodriguez; Shu-Hui Chen

As a result of our core SAR effort, we discovered a large number of 3-amido pseudomycin B (PSB) analogues (e.g., 4e LY448212 and 5b LY448731) that retain good in vitro and in vivo (IP) activities against Candida and Cryptococcus without inherent tail vein irritation. Several dimethylamino termini bearing 3-amides (e.g., 5b) also exhibited improved potency against Aspergillus in vitro. When evaluated in a two-week rat toxicology study, it was found that all animals receiving 4e (up to 75 mg/kg) were found to be normal. On the basis of these observations, we are convinced that it is possible to broaden the antifungal spectrum and improve the safety profile of pseudomycin analogues at the same time.


Bioorganic & Medicinal Chemistry Letters | 1999

The synthesis of water soluble prodrugs analogs of echinocandin B.

Michael J. Rodriguez; Vasu Vasudevan; James Andrew Jamison; Peter Stanley Borromeo; William Wilson Turner

A facile synthesis of phosphonate and phosphate ester prodrugs on the phenolic hydroxy of two echinocandin semisynthetic derivatives is reported. The water solubility and stability profiles of the ECB compounds varied with the choice of alkyl group used. In some cases, the ester prodrugs with small aliphatic side chains retained antifungal activity while enhancing water solubility.


Bioorganic & Medicinal Chemistry Letters | 2001

Prodrugs of 3-amido bearing pseudomycin analogues: novel antifungal agents

Xicheng Sun; Douglas J. Zeckner; Yan-Zhi Zhang; Roberta K Sachs; William L. Current; Michael J. Rodriguez; Shu-Hui Chen

With the aim of identifying safer pseudomycin derivatives, we synthesized and evaluated a number of N-acyloxymethyl carbamate linked prodrugs of 3-amido pseudomycin analogues. To our satisfaction, all of the prodrug-amide combinations prepared exhibited good in vivo efficacy against murine Candidiasis. When evaluated in a dose elevation study, all of the newly synthesized combinations (e.g., 4A, 6A, 8A, and 8B) demonstrated improved toxicity profiles in comparison to their corresponding 3-amides as well as the parent pseudomycin B.


Bioorganic & Medicinal Chemistry Letters | 2000

Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1.

James Andrew Jamison; Stuart Levy; Xicheng Sun; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez; William Wilson Turner; Shu-Hui Chen

We have described herein the syntheses of three novel series of aromatic ring containing pseudomycin side-chain analogues. Preliminary biological evaluations of these analogues clearly indicate that it is possible to synthesize rigid pseudomycin side-chain analogues without compromising in vitro antifungal activity.


Chemistry: A European Journal | 2016

N-Heteroarylation of Optically Pure α-Amino Esters using the Pd-PEPPSI-IPentCl-o-picoline Pre-Catalyst

Sepideh Sharif; David Mitchell; Michael J. Rodriguez; Jennifer L. Farmer; Michael G. Organ

A robust, mild, and efficient method for the Pd-catalyzed N-heteroarylation of optically pure α-amino esters was developed. Dichloro[1,3-bis(2,6-di-3-pentylphenyl)imidazol-2-ylidene](o-picoline)palladium(II) (Pd-PEPPSI-IPentCl -o-picoline; PEPPSI=pyridine enhanced pre-catalyst preparation, stabilization, and initiation) was shown to effectively couple a variety of amino acids as the tert-butyl ester with heteroaryl chlorides in high yields and with excellent stereoretention of the acidic proton adjacent to the ester. Control experiments revealed that racemization is base-mediated, with no evidence of Pd-mediated β-hydride elimination when using Pd-PEPPSI-IPentCl , and that racemization occurs only after the product is formed, that is, the non-arylated starting amino ester does not deprotonate under our reaction conditions. Studies also revealed that increasing the steric bulk of the ester moiety on the amino acid (e.g., ethyl to tert-butyl) drastically slows racemization of the product.


Bioorganic & Medicinal Chemistry Letters | 2000

Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2.

Shu-Hui Chen; Xicheng Sun; Robert Boyer; Jonathan W. Paschal; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez

A series of aliphatic side-chain analogues of pseudomycin was synthesized and evaluated during the course of our side-chain SAR effort. We found that several of the pseudomycin side-chain analogues (e.g., 10) exhibited good in vitro activity against all three major fungi responsible for systemic fungal infections.

Collaboration


Dive into the Michael J. Rodriguez's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge